Max Zeiberg
About Max Zeiberg
Max Zeiberg serves as the Vice President of Business Development at Sana Biotechnology, Inc., having previously held leadership roles at several biotechnology companies, including Gilead Sciences and Graphite Bio.
Current Role at Sana Biotechnology
Max Zeiberg serves as the Vice President of Business Development at Sana Biotechnology, Inc. since 2023. In this role, he is responsible for driving business strategies and partnerships that align with the company's mission in the biotechnology sector. His leadership focuses on enhancing growth opportunities and fostering collaborations that support innovative therapies.
Previous Experience in Business Development
Prior to his current position, Max Zeiberg held several key roles in business development. He worked at Graphite Bio as Vice President of Business Development from 2020 to 2022. Before that, he was the Director of Business Development at Counsyl from 2014 to 2017. His experience also includes serving as Senior Director of Corporate Development at Gilead Sciences from 2017 to 2020.
Education and Academic Background
Max Zeiberg earned a Master of Business Administration (MBA) from the Kellogg School of Management at Northwestern University, where he studied from 2012 to 2014. He also participated in an MBA Exchange Program at The Hong Kong University of Science and Technology in 2014. Earlier, he completed a Bachelor of Science in Biomedical Engineering at Columbia University from 2004 to 2008.
Early Career and Internships
Max Zeiberg began his career as an Associate Consultant at ZS, where he worked from 2008 to 2012 in New York. He also gained experience as an MBA Intern in Business Development at Genentech for two months in 2013. These early roles provided him with foundational skills in consulting and business development within the healthcare sector.